Influenza Vaccination Coverage in Children: How Has COVID-19 Influenced It? A Review of Five Seasons (2018-2023) in Central Catalonia, Spain

被引:2
|
作者
Burgaya-Subirana, Silvia [1 ,2 ]
Balaguer, Monica [2 ,3 ]
Miro Catalina, Queralt [4 ]
Sola, Laia [4 ]
Ruiz-Comellas, Anna [2 ,4 ,5 ]
机构
[1] Inst Catala Salut, EAP Manlleu, Pediat Dept, Gerencia Atencio Primaria & Comunitat Catalunya Ce, C-Castellot 17, Manlleu 08560, Barcelona, Spain
[2] Univ Vic, Univ Cent Catalunya, Fac Med, Cta Roda 70, Barcelona 08500, Spain
[3] Hosp Sant Joan Deu Barcelona, Pediat Intens Care Unit, Passeig Sant Joan Deu 2, Esplugas de Llobregat 08950, Spain
[4] Inst Catala Salut, Res Dept, Gerencia Atencio Primaria & Comunitat Catalunya Ce, C-P Estats 13-15, Barcelona 08272, Spain
[5] Inst Catala Salut, Med Dept, EAP Sant Joan De Vilatorrada, Gerencia Atencio Primaria & Comunitat Catalunya Ce, Avinguda Torrent Canigo 0, Catalonia 08250, Spain
关键词
influenza vaccine; COVID-19; vaccination coverage; children; PRIMARY-CARE; STRATEGIES; BURDEN; ADULTS; TRENDS; RATES;
D O I
10.3390/vaccines12080925
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Influenza vaccination is the main method of preventing influenza. Vaccination is recommended for certain individuals with diseases that could cause complications in the case of flu infection. The objective of this retrospective observational study was to examine influenza vaccination coverage in patients with risk factors, to describe the characteristics of those vaccinated and to study the influence of COVID-19. The study population was children under 14 years old with risk factors between 2018/19 and 2022/23 in Central Catalonia, sourced through the electronic database of the Catalan Institute of Health. The association of influenza vaccination data with sociodemographic data and risk factors was performed by bivariate and multivariate analysis. A total of 13,137 children were studied. Of those, 4623 had received the influenza vaccine in at least one season. The average influenza vaccination rate was 28.8%. The statistically significant factors associated with vaccination were age and having certain risk factors: asthma, diabetes, haemoglobinopathies and clotting disorders. In all seasons, the immigrant population was vaccinated more than the native population p < 0.05, except for the COVID-19 season (2020/21), where no differences were observed. Of those vaccinated, 7.1% had been vaccinated for 5 consecutive years. Influenza vaccination coverage in the paediatric age group was low. Vaccination promotion measures must be implemented. COVID-19 meant an increase in vaccination of the native population to the same level as that of the immigrant population.
引用
收藏
页数:13
相关论文
共 18 条
  • [1] Impact of COVID-19 on Respiratory Virus Infections in Children, Japan, 2018-2023
    Takashita, Emi
    Shimizu, Kohei
    Kawakami, Chiharu
    Momoki, Tomoko
    Saikusa, Miwako
    Ozawa, Hiroki
    Kumazaki, Makoto
    Usuku, Shuzo
    Tanaka, Nobuko
    Senda, Ryuichi
    Okubo, Ichiro
    Fujisaki, Seiichiro
    Nagata, Shiho
    Morita, Hiroko
    Miura, Hideka
    Watanabe, Kayo
    Nakauchi, Mina
    Matsuzaki, Yoko
    Watanabe, Shinji
    Hasegawa, Hideki
    Kawaoka, Yoshihiro
    IMMUNITY INFLAMMATION AND DISEASE, 2025, 13 (03)
  • [2] Impact of the COVID-19 Pandemic on Influenza Vaccination Coverage of Healthcare Personnel in Alicante, Spain
    Guerrero-Soler, Maria
    Gras-Valenti, Paula
    Platas-Abenza, Guillermo
    Sanchez-Paya, Jose
    Sanjuan-Quiles, Angela
    Chico-Sanchez, Pablo
    VACCINES, 2024, 12 (04)
  • [3] Surveillance of seasonal influenza viruses during the COVID-19 pandemic in Tokyo, Japan, 2018-2023, a single-center study
    Takahashi, Hidenori
    Nagamatsu, Hiroki
    Yamada, Yuka
    Toba, Naoya
    Toyama-Kousaka, Mio
    Ota, Shinichiro
    Morikawa, Miwa
    Shinoda, Masahiro
    Takano, Syunsuke
    Fukasawa, Suzuko
    Park, Kaeyoung
    Yano, Takahiko
    Mineshita, Masamichi
    Shinkai, Masaharu
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2024, 18 (01)
  • [4] Influenza, Tdap, and COVID-19 Vaccination Coverage and Hesitancy Among Pregnant Women - United States, April 2023
    Razzaghi, Hilda
    Kahn, Katherine E.
    Calhoun, Kayla
    Garacci, Emma
    Skoff, Tami H.
    Ellington, Sascha R.
    Jatlaoui, Tara C.
    Black, Carla L.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2023, 72 (39): : 1065 - 1071
  • [5] The Impact of the COVID-19 Pandemic on Influenza Vaccination Coverage Among Young US Children: A Socioeconomic Analysis
    Saleh, Tawny
    Shirazi, Mina
    Cambou, Mary C.
    Nielsen-Saines, Karin
    COVID, 2025, 5 (02):
  • [6] Influenza, Updated COVID-19, and Respiratory Syncytial Virus Vaccination Coverage Among Adults - United States, Fall 2023
    Black, Carla L.
    Kriss, Jennifer L.
    Razzaghi, Hilda
    Patel, Suchita A.
    Santibanez, Tammy A.
    Meghani, Mehreen
    Tippins, Ashley
    Stokley, Shannon
    Chatham-Stephens, Kevin
    Dowling, Nicole F.
    Peacock, Georgina
    Singleton, James A.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2023, 72 (51): : 1377 - 1382
  • [7] Impact of the COVID-19 lockdown on routine childhood vaccination coverage rates in Catalonia (Spain): a public health register-based study
    Martinez-Marcos, Montse
    Zabaleta-del-Olmo, Edurne
    Gomez-Duran, Esperanza-Luisa
    Rene-Rene, Anna
    Cabezas-Pena, Carmen
    PUBLIC HEALTH, 2023, 218 : 68 - 74
  • [8] Using Influenza Vaccination Location Data from the 2018 Behavioral Risk Factor Surveillance System (BRFSS) to Expand COVID-19 Vaccination Coverage
    Fonzi, Victoria
    Thapa, Kiran
    Luitel, Kishor
    Padilla, Heather
    Harris, Curt
    Khan, M. Mahmud
    Nowak, Glen
    Rajbhandari-Thapa, Janani
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (15)
  • [9] Co-Administration of Influenza and COVID-19 Vaccines: Policy Review and Vaccination Coverage Trends in the European Union, UK, US, and Canada between 2019 and 2023
    Achterbergh, Roel C. A.
    McGovern, Ian
    Haag, Mendel
    VACCINES, 2024, 12 (02)
  • [10] How has research on the effectiveness and safety of COVID-19 vaccination been evaluated: a scope review with emphasis on CoronaVac
    Alzate-Angel, Juan C.
    Aviles-Vergara, Paula A.
    Arango-Londono, David
    Concha-Eastman, Alberto
    Garces-Hurtado, Anthony
    Lopez-Carvajal, Liliana
    Minotta, Ingrid L.
    Ortega-Lenis, Delia
    Quintero, Geraldine
    Reina-Bolanos, Sebastian
    Reina-Bolanos, Carlos A.
    Roa, Pablo
    Sanchez-Orozco, Melanie
    Tovar-Acero, Catalina
    Arbelaez-Montoya, Maria P.
    FRONTIERS IN PUBLIC HEALTH, 2024, 12